Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Objectives To summarize quantitatively the literature comparing hypothalamic-pituitary-adrenal (HPA) axis function between depressed and nondepressed individuals and to describe the important sources of variability in this literature. These sources include methodological differences between studies, as well as demographic or clinical differences between depressed samples. Methods The current study used meta-analytic techniques to compare 671 effect sizes (cortisol, adrenocorticotropic hormone, or corticotropin-releasing hormone) across 361 studies, including 18,454 individuals. Results Although depressed individuals tended to display increased cortisol (d = 0.60; 95% confidence interval [CI], 0.54-0.66) and adrenocorticotropic hormone levels (d = 0.28; 95% CI, 0.16-0.41), they did not display elevations in corticotropin-releasing hormone (d = 0.02; 95% CI, -0.47-0.51). The magnitude of the cortisol effect was reduced by almost half (d = 0.33; 95% CI, 0.21-0.45) when analyses were limited to studies that met minimal methodological standards. Gender did not significantly modify any HPA outcome. Studies that included older hospitalized individuals reported significantly greater cortisol differences between depressed and nondepressed groups compared with studies with younger outpatient samples. Important cortisol differences also emerged for atypical, endogenous, melancholic, and psychotic forms of depression. Conclusions The current study suggests that the degree of HPA hyperact…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional studies on the pathological mechanism of depression have suggested that the HPA axis is hyperactive in MDD patients and that sensitivity to negative feedback is decreased. 15”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [15]
In the citing paper
“Chronic hyperactivation of the stress system is related to hypersecretion of corticotropin releasing hormone and arginine-vasopressin (CRH, AVP) by the hypothalamus and ACTH hypersecretion by the pituitary (76), resulting in higher circulating cortisol levels due also to an “insensitive” negative glucocorticoid (GC) feedback of the HPA axis loop (77).”
From Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation (2019) · cites this paper as [77]
In the citing paper
“A further metaanalysis of 18,374 adult individuals found higher cortisol in MDD when measured continuously throughout the day, with morning times revealing the least difference between the groups.”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“Post DST, higher cortisol and reduced ACTH were found with MDD compared to non-depressed in a metanalysis of 1,639 adults (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“ACTH was also higher overall in MDD patients; however, there was no difference between control and depressed patients at any one time of day (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Dickerson, S. S., & Kemeny, M. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.3.355 · Cited by 5,881
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Fixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Miller, G. E., Chen, E., & Zhou, E. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.25 · Cited by 2,467 · cited 1×
“This is important because it is these processes, rather than increased cortisol levels, that are more closely linked to disease outcomes (18,35).”
BackgroundSelf-citationThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653 · cited 1×
“These individuals are, therefore, more likely to be at risk for conditions where excessive cortisol is thought to play a pathogenic role, such as Type II diabetes, osteoporosis, or dementia (33,34).”
BackgroundGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Depression and cortisol responses to psychological stress: A meta-analysis
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.010 · Cited by 1,194
Cited by
Items 301–400 of 1,305
Liang, L., Zhou, H., Zhang, S., Yuan, J., & Wu, H. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.09.014 · Cited by 56
“Dementia and Depression are difficult problems because of their unresolved etiology, complex pathogenic factors, and unknown pathogenesis in the field of neuroscience[11, 12].”
Emerging role of amyloid beta in stress response: Implication for depression and diabetes
Morgese, M. G., Schiavone, S., & Trabace, L. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.031 · Cited by 56
Seeking an Objective Diagnosis of Depression
Bilello, J. A. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0076 · Cited by 48
Gerber, M., Imboden, C., Beck, J., Brand, S., Colledge, F., Eckert, A., Holsboer-Trachsler, E., Pühse, U., & Hatzinger, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051419 · Cited by 38
“Moreover, we did not find a link between age and stress reactivity although previous studies suggested that the level of HPA axis dysregulation might increase with age among people with depression [20,21].”
BackgroundResultChristiansen, S., Bouzinova, E. V., Palme, R., & Wiborg, O. (2012) · Stress · doi:10.3109/10253890.2011.654370 · Cited by 55
Daily family stress and HPA axis functioning during adolescence: The moderating role of sleep
Chiang, J. J., Tsai, K. M., Park, H., Bower, J. E., Almeida, D. M., Dahl, R. E., Irwin, M. R., Seeman, T. E., & Fuligni, A. J. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.009 · Cited by 53
“, age, gender, ethnicity, and parental education) and depressive symptoms were included as covariates in all models given that they have been associated with HPA axis functioning (DeSantis et al., 2007; Dowd et al., 2009; Stetler and Miller, 2011; Stroud et al., 2009; Uhart et al., 2006).”
MethodThe Potential for Outdoor Nature-Based Interventions in the Treatment and Prevention of Depression
Owens, M., & Bunce, H. L. I. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.740210 · Cited by 56
Depressive symptoms and immune transcriptional profiles in late adolescents
Chiang, J. J., Cole, S. W., Bower, J. E., Irwin, M. R., Taylor, S. E., Arevalo, J. M. G., & Fuligni, A. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.004 · Cited by 55
“Depression has been associated with heightened levels of cortisol (Stetler and Miller, 2011), which may subsequently contribute to the development of glucocorticoid resistance in immune cells, a state in which immune cells’ gluco-”
Finch, L. E., Cummings, J. R., & Tomiyama, A. J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.04.022 · Cited by 55
Voluntary running influences the efficacy of fluoxetine in a model of postpartum depression
Gobinath, A. R., Richardson, R. J., Chow, C., Workman, J. L., Lieblich, S. E., Barr, A. M., & Galea, L. A. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.017 · Cited by 54
“Together with the stress recovery measure, this indicates that our dose of CORT increased and flattened HPA axis tone to a level relevant to postpartum female rat physiology, thus modelling hypercortsolemia and depression (Stetler and Miller, 2011) including PPD (Seth et al.”
BackgroundSingle-subject research in psychiatry: facts and fictions
Zuidersma, M., Riese, H., Snippe, E., Booij, S. H., Wichers, M., & Bos, E. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.539777 · Cited by 54
Biosensors for psychiatric biomarkers in mental health monitoring
Wang, L., Hu, Y., Jiang, N., & Yetisen, A. K. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116242 · Cited by 54
In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation
Davis, M. T., Hillmer, A., Holmes, S. E., Pietrzak, R. H., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G. A., Carson, R. E., Krystal, J. H., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818871116 · Cited by 50
“By contrast, there is significant evidence of HPA axis hyperactivity in MDD, including heightened basal cortisol relative to comparison controls (29).”
BackgroundStatins in the treatment of depression: Hype or hope?
Köhler-Forsberg, O., Otte, C., Gold, S. M., & Østergaard, S. D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107625 · Cited by 51
Wilmes, L., Collins, J. M., O’Riordan, K. J., O’Mahony, S. M., Cryan, J. F., & Clarke, G. A. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14095 · Cited by 54
Morelli, V., Ghielmetti, A., Caldiroli, A., Grassi, S., Siri, F. M., Caletti, E., Mucci, F., Aresta, C., Passeri, E., Pugliese, F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa695 · Cited by 54
“Indeed, pseudo-CS is characterized by an increase in HPA axis activity, and two meta-analyses showed higher ACTH levels in both bipolar and depressed individuals compared with healthy subjects (22, 44).”
ResultVerhoeven, J. E., Révész, D., Wolkowitz, O. M., & Penninx, B. W. J. H. (2014) · BioEssays · doi:10.1002/bies.201400068 · Cited by 45
Structural studies of the hypothalamus and its nuclei in mood disorders
Schindler, S., Geyer, S., Strauß, M., Anwander, A., Hegerl, U., Turner, R., & Schönknecht, P. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.005 · Cited by 52
“A recent meta-analysis by Stetler and Miller (2011) confirmed several indicators of HPA-axis hyperactivity in unipolar depression, such as elevated cortisol levels and disturbed dexamethasone suppression of cortisol release.”
Hypothalamus enlargement in mood disorders
Schindler, S., Schmidt, L., Stroske, M., Storch, M., Anwander, A., Trampel, R., Strauß, M., Hegerl, U., Geyer, S., & Schönknecht, P. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12958 · Cited by 52
Wang, M., Yang, L., Chen, Z., Dai, L., Xi, C., Wu, X., Wu, G., Wang, Y., & Hu, J. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05895-8 · Cited by 52
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
Malik, S., Singh, R., Arora, G., Dangol, A., & Goyal, S. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.1.12 · Cited by 42
“these indicate that hypercortisolemia is linked with stress and a recurrent attenuation of cortisol awakening responses [111,112].”
BackgroundSchatzberg, A. F. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.916414 · Cited by 51
“Most recently, Stetler and Miller (2011) reaffi rmed the relationship between psychosis and hypercortisolemia in major depression.”
BackgroundSorgdrager, F. J. H., Doornbos, B., Penninx, B. W. J. H., de Jonge, P., & Kema, I. P. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.052 · Cited by 51
“MARK et al., 2010; Lopez-Duran et al., 2009; Stetler and Miller, 2011).”
Golden, S. H., Sánchez, B. N., Wu, M., Champaneri, S., Diez Roux, A. V., Seeman, T., & Wand, G. S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.032 · Cited by 43
“Depressive disorders have been cross-sectionally associated with a mixture of HPA abnormalities, including hypercortisolism (Stetler and Miller, 2011) and a blunted diurnal slope (Champaneri et al.”
Hassan, N. M., Salim, H. S., Amaran, S., Yunus, N. I., Yusof, N. A., Daud, N., & Fry, D. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282538 · Cited by 52
“Indeed, individuals with depression have been found to have higher levels of cortisol and pro-inflammatory cytokines, but this depends on both the severity and stage of the depression [46].”
BackgroundHyperinsulinemia Associated Depression
Sarwar, H., Rafiqi, S. I., Ahmad, S., Jinna, S., Khan, S. A., Karim, T., Qureshi, O., Zahid, Z. A., Elhai, J. D., Levine, J. C., et al. (2022) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514221090244 · Cited by 51
A two-year follow-up study of salivary cortisol concentration and the risk of depression
Grynderup, M. B., Kolstad, H. A., Mikkelsen, S., Andersen, J. H., Bonde, J. P., Buttenschøn, H. N., Kærgaard, A., Kærlev, L., Rugulies, R., Thomsen, J. F., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.013 · Cited by 51
Bot, M., Milaneschi, Y., Penninx, B. W. J. H., & Drent, M. L. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.028 · Cited by 50
High-Intensity Aerobic Exercise Acutely Increases Brain-derived Neurotrophic Factor
ROSS, R. E., SALADIN, M. E., GEORGE, M. S., & GREGORY, C. M. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001969 · Cited by 50
The effects of an anticipated challenge on diurnal cortisol secretion
Wetherell, M. A., Lovell, B., & Smith, M. A. (2015) · Stress · doi:10.3109/10253890.2014.993967 · Cited by 50
Bustamante, A. C., Aiello, A. E., Guffanti, G., Galea, S., Wildman, D. E., & Uddin, M. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.09.016 · Cited by 50
“…HPA axis regulation have been previously implicated in meta-analyses and multiple studies (Belvederi Murri et al., 2014; Dienes et al., 2013; Stetler and Miller, 2011; Vreeburg et al., 2009), therefore, it is plausible that our study participants with lifetime MDD have altered cortisol…”
BackgroundCiocan, D. M., Cassard, A., Becquemont, L., Verstuyft, C., Voican, C. S., Asmar, K. E., Colle, R., David, D. J. P., Trabado, S., Fève, B., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200159 · Cited by 52
“J Psychiatry Neurosci 2021;46(3) E367 their metabolic pathways — may help to improve the treatment of patients experiencing a major depressive episode.”
BackgroundInfluentialGex-Fabry, M., Jermann, F., Kosel, M., Rossier, M. F., Van der Linden, M., Bertschy, G., Bondolfi, G., & Aubry, J.-M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.011 · Cited by 43
“Hyperactivity of the hypothalamic-pituitary-adrenal axis (HPA) in depression has been challenged in recent reviews that pointed at modest effects and large heterogeneity between studies (Knorr et al., 2010; Stetler and Miller, 2011).”
BackgroundLopresti, A. L., Smith, S. J., & Drummond, P. D. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1892253 · Cited by 50
“tric disorders such as depression [4,5], bipolar disorder [6], schizophrenia [7], borderline personality disorder [8,9], and post-traumatic stress disorder (PTSD) [10].”
BackgroundMetabolomic biosignature differentiates melancholic depressive patients from healthy controls
Liu, Y., Yieh, L., Yang, T., Drinkenburg, W., Peeters, P., Steckler, T., Narayan, V. A., Wittenberg, G., & Ye, J. (2016) · BMC Genomics · doi:10.1186/s12864-016-2953-2 · Cited by 45
“Although cortisol changes are present in multiple subtypes of MDD, a recent metaanalysis of 354 studies found that the effect size for cortisol was larger when restricted to just melancholic depressed subjects [45].”
BackgroundMuscatello, R. A., & Corbett, B. A. (2018) · Autism Research · doi:10.1002/aur.1879 · Cited by 45
“As HPA axis dysfunction is associated with increased prevalence of internalizing symptoms [see Stetler & Miller, 2011, for review], changes in HPA functioning during pubertal development are important to consider when investigating the increased rates of psychiatric symptoms in adolescents.”
BackgroundAlshehri, T., Boone, S. C., de Mutsert, R., Penninx, B. W. J. H., Rosendaal, F. R., le Cessie, S., Milaneschi, Y., & Mook-Kanamori, D. O. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104429 · Cited by 49
Walther, A., Mackens-Kiani, A., Eder, J., Herbig, M., Herold, C., Kirschbaum, C., Guck, J. R., Wittwer, L. D., Beesdo‐Baum, K., & Kräter, M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01911-3 · Cited by 49
“A large body of evidence indicates depressive disorders to be associated with increased HPA-activity resulting in elevated cortisol levels [31].”
BackgroundDemuyser, T., Deneyer, L., Bentea, E., Albertini, G., Liefferinge, J. V., Merckx, E., Prins, A. D., Bundel, D. D., Massie, A., & Smolders, I. J. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.12.018 · Cited by 49
“The effect of chronic stress is mainly mediated through elevated glucocorticoid levels and activation of the hypothalamic–pituitary– adrenal (HPA) axis [5].”
BackgroundSawamoto, A., Okuyama, S., Amakura, Y., Yoshimura, M., Yamada, T., Yokogoshi, H., Nakajima, M., & Furukawa, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102133 · Cited by 48
“The “BDNF hypothesis of depression”, which states that BDNF is involved in the pathogenesis of depression [2,3], is based on findings showing that (1) long-term stress activates the hypothalamic-pituitary-adrenal (HPA) axis, resulting in the excess secretion of glucocorticoids [4,5], which is linked to the suppressed…”
BackgroundMocking, R. J. T., Verburg, H. F., Westerink, A. M., Assies, J., Vaz, F. M., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.04.027 · Cited by 50
Kofman, Y. B., Eng, Z. E., Busse, D., Godkin, S., Campos, B., Sandman, C. A., Wing, D. A., & Yim, I. S. (2019) · Biological Psychology · doi:10.1016/j.biopsycho.2019.01.016 · Cited by 48
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Zadeh, F. H., Wilson, D. R., & Agrawal, D. K. (2023) · Archives of Microbiology & Immunology · doi:10.26502/ami.93650103 · Cited by 48
McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00436-8 · Cited by 47
Chen, X., Guo, J., Han, P., Fu, L., Jia, L., Yu, H., Yu, X., Hou, L., Wang, L., Zhang, W., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.07.017 · Cited by 47
Choi, K. W., Na, E. J., Fava, M., Mischoulon, D., Cho, H., & Jeon, H. J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.047 · Cited by 47
Viikki, M., Kampman, O., Anttila, S. A. K., Illi, A., Setälä-Soikkeli, E., Huuhka, M., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.023 · Cited by 47
Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid
Morgese, M. G., Tucci, P., Mhillaj, E., Bové, M., Schiavone, S., Trabace, L., & Cuomo, V. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9809-2 · Cited by 47
“High cortisol levels, and thus HPA-axis hyperactivity, have been indicated as the most frequent alteration in patients affected by major depression disorder [44].”
BackgroundAllostatic load and systemic comorbidities in psychiatric disorders
Finlay, S., Rudd, D., McDermott, B., & Sarnyai, Z. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105726 · Cited by 38
Psychophysiological concomitants of burnout: Evidence for different subtypes
Traunmüller, C., Stefitz, R., Gaisbachgrabner, K., Hofmann, P., Roessler, A., & Schwerdtfeger, A. R. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.01.009 · Cited by 47
Yosaee, S., Soltani, S., Esteghamati, A., Motevalian, S. A., Tehrani-Doost, M., Clark, C. C. T., & Jazayeri, S. (2020) · Nutrition · doi:10.1016/j.nut.2019.110601 · Cited by 46
“A growing evidence base 35 indicates that there are abnormalities in the hypothalamic-pituitary-adrenal axis, particularly in 36 the regulation of cortisol, in clinically depressed patients, which is, in turn, related to obesity 37 (10-12).”
BackgroundIsa, A., Bernstein, I. H., Trivedi, M. H., Mayes, T. L., Kennard, B. D., & Emslie, G. J. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0127 · Cited by 46
“To date, studies have found melancholic depression to be associated with hypothalamic–pituitary–adrenal (HPA) axis dysregulation, whereas atypical depression is associated with lower cortisol levels and metabolic dysregulation (Wong et al. 2000; Gold and Chrousos 2002; Stetler and Miller 2011; Lamers et al. 2012).”
The relationship between fibromyalgia, stress and depression
Thiagarajah, A. S., Guymer, E. K., Leech, M. T., & Littlejohn, G. O. (2014) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.14.30 · Cited by 46
Mewes, R. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1033203 · Cited by 48
“While the activity of the HPA axis is assumed to be reduced in individuals with impairing medically unexplained symptoms (79–81), HPA axis hyperactivity is apparent in persons with depressive disorders (82, 83).”
BackgroundMarkey, L., Hooper, A., Melon, L. C., Baglot, S., Hill, M. N., Maguire, J., & Kumamoto, C. A. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104808 · Cited by 45
Perceived stress and its predictors in people with epilepsy
Moon, H., Seo, J.-G., & Park, S.-P. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.06.038 · Cited by 45
“According to previous studies, factors such as depression [3], anxiety [4], and sleep disturbance [5] can influence stress systems such as the HPA axis.”
Personalized medicine in major depressive disorder — Opportunities and pitfalls
Miller, D. B., & O'Callaghan, J. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.021 · Cited by 45
“Other strategies used in the search for clinically viable biomarkers have concentrated on the further characterization of MDD using brain electroencephalographic and imaging techniques, as well as the measurement of presumed blood indicators such as inflammatory cytokines, HPA axis hormones, metabolic markers and grow…”
MethodShared Dysregulation of Homeostatic Brain-Body Pathways in Depression and Type 2 Diabetes
Hoogendoorn, C. J., Delgado, J. F. R., & Gonzalez, J. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0923-y · Cited by 45
Medel‐Matus, J., Orozco-Suárez, S. A., & Escalante, R. G. (2022) · Epilepsia Open · doi:10.1002/epi4.12576 · Cited by 45
Kahl, K. G., Georgi, K., Bleich, S., Muschler, M., Hillemacher, T., Hilfiker-Kleinert, D., Schweiger, U., Ding, X., Kotsiari, A., & Frieling, H. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.002 · Cited by 44
Antidepressant and Anti-Neuroinflammatory Effects of Bangpungtongsung-San
Park, B.-K., Kim, N. S., Kim, Y. R., Yang, C., Jung, I. C., Jang, I., Seo, C., Choi, J. J., & Lee, M. Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00958 · Cited by 44
Plieger, T., Felten, A., Splittgerber, H., Duke, É., & Reuter, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.10.020 · Cited by 44
Gao, X., Liang, M., Fang, Y., Zhao, F., Tian, J., Zhang, X., & Qin, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00995 · Cited by 44
“, 2017), while hyperactivity of the HPA axis has been found in depression (Stetler and Miller, 2011).”
BackgroundTchekalarova, J. D., Nenchovska, Z., Atanasova, D., Atanasova, M., Kortenska, L., Stefanova, M. O., Alova, L. G., & Lazarov, N. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.043 · Cited by 44
Peyrot, C., Brouillard, A., Morand‐Beaulieu, S., & Marin, M. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103615 · Cited by 45
Morgese, M. G., & Trabace, L. (2016) · Brain Sciences · doi:10.3390/brainsci6030024 · Cited by 46
“Significantly, alteration in stress response, both in human and animal models, has been linked to many psychiatric diseases, particularly depression [100] and psychosis [101].”
BackgroundZhang, H., Xu, Y., Li, Y., Lu, M., Shi, S., Jian-lin, J., & Wang, L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.099 · Cited by 44
Emerging effects of temperature on human cognition, affect, and behaviour
Fischer, S., Naegeli, K., Cardone, D., Filippini, C., Merla, A., Hanusch, K.-U., & Ehlert, U. (2024) · Biological Psychology · doi:10.1016/j.biopsycho.2024.108791 · Cited by 44
“Elevated circulating concentrations of these hormones are some of the most well established findings in mental disorders (e.g., Fischer and Ehlert, 2019; Maletic et al., 2017; Stetler and Miller, 2011) and it is thus conceivable that heat stress may foster symptom development.”
BackgroundZhao, K., Zhang, Y., Yang, S., Xiang, L., Wu, S., Dong, J., Li, H., Yu, H., & Hu, W. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1538026 · Cited by 45
Lemogne, C., Nabi, H., Melchior, M., Goldberg, M., Limosin, F., Consoli, S. M., & Zins, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.015 · Cited by 43
Therapeutic potential of plant iridoids in depression: a review
Kou, Y., Li, Z., Yang, T., Shen, X., Wang, X., Li, H., Zhou, K., Li, L., Xia, Z., Zheng, X., et al. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2136206 · Cited by 44
“…investigation reveals that individuals who have been sexually or physically abused as children have significantly increased HPA axis activity when exposed to standardized psychosocial stressors or following endocrine tests that seek to suppress HPA activity as adults (Stetler and Miller 2011).”
BackgroundInfluentialMajor depressive disorder: Biomarkers and biosensors
Dadkhah, M., Jafarzadehgharehziaaddin, M., Molaei, S., Akbari, M., Gholizadeh, N., & Fathi, F. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117437 · Cited by 43
Sex differences in sleep, anhedonia, and HPA axis activity in a rat model of chronic social defeat
Page, G. G., Opp, M. R., & Kozachik, S. L. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.002 · Cited by 37
“This is an open access article u hypothalamic-pituitary-adrenal (HPA) axis dysregulation (American Psychiatric Association, 2013; Becker et al., 2008; Kamphuis et al., 2015; Patki et al., 2013; Razzoli et al., 2007; Rygula et al., 2006; Stetler and Miller, 2011).”
BackgroundJani, B. D., McLean, G., Nicholl, B. I., Barry, S. J. E., Sattar, N., Mair, F. S., & Cavanagh, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00018 · Cited by 37
“The Diagnostics and Statistical Manual (DSM)-IV’s diagnosis of a MDD requires the presence of at least 5 out of 9 symptoms of depression with significant impairment or distress, while those presenting with at least 2 but less than 5 symptoms and no previous history of MDD are stratified as sub threshold or minor depre…”
ResultInfluentialDepressive symptom composites associated with cortisol stress reactivity in adolescents
Morris, M. C., Kouros, C. D., Mielock, A. S., & Rao, U. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.023 · Cited by 30
“Hypothalamic-pituitary-adrenocortical (HPA) alterations in youth with major depressive disorder (MDD) are not universal (for reviews, see Lopez-Duran et al. (2009) and Stetler and Miller (2011)).”
BackgroundInfluentialSuzuki, H., Belden, A. C., Spitznagel, E., Dietrich, R., & Luby, J. L. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.06.038 · Cited by 33
Scott, K. M., Saha, S., Lim, C. C. W., Aguilar‐Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C. L., Bromet, E. J., Bruffaerts, R., Caldas‐de‐Almeida, J. M., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718000363 · Cited by 42
“…via chronic elevation or dysregulation of the physiological stress response pathways given that considerable evidence has accrued for these biological mechanisms in the associations of depression and anxiety with subsequent cardio-metabolic conditions (Davies et al. 2010; Stetler & Miller, 2011).”
BackgroundFrom Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation
Krasner, H., Ong, C. V., Hewitt, P., & Vida, T. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073219 · Cited by 42
“However, cortisol responses in mood disorders are het-Int erogeneous: some patients exhibit HPA hyperactivity, while others display blunted cortisol responses [182,183].”
IUPHAR review: Microbiota-gut-brain axis and its role in neuropsychiatric disorders
Lee, S.-H., Han, C., & Shin, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107749 · Cited by 42
Doerr, J. M., Fischer, S., Nater, U. M., & Strahler, J. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.12.005 · Cited by 45
Révész, D., Verhoeven, J. E., Milaneschi, Y., & Penninx, B. W. J. H. (2016) · Psychological Medicine · doi:10.1017/s0033291716000891 · Cited by 39
Walker, A. J., Burnett, S. A., Hasebe, K., McGillivray, J., Gray, L. J., McGee, S. L., Walder, K. R., Berk, M., & Tye, S. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.033 · Cited by 41
Inflammatory markers and cortisol parameters across depressive subtypes in an older cohort
Veltman, E. M., Lamers, F., Comijs, H. C., Stek, M. L., van der Mast, R. C., & Rhebergen, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.080 · Cited by 41
Schumacher, S., Niemeyer, H., Engel, S., Cwik, J. C., & Knaevelsrud, C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.006 · Cited by 42
Hubers, A. A. M., van der Mast, R. C., Pereira, A. M., Roos, R. A. C., Veen, L. J., Cobbaert, C. M., van Duijn, E., & Giltay, E. J. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12255 · Cited by 41
Cortisol response to stress as a predictor for suicidal ideation in youth
Shalev, A., Porta, G., Biernesser, C. L., Zelazny, J. M., Payne, M. W., Melhem, N., & Brent, D. A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.053 · Cited by 42
Fiacco, S., Gordon, J. L., Andersen, E., Kozik, R. G., Neely, O., Schiller, C. E., Muñoz, M. J., Rubinow, D. R., & Girdler, S. S. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105851 · Cited by 41
Stanton, L. M., Price, A. J., & Manning, E. E. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13268 · Cited by 43
“logical inconsistencies, patient heterogeneity, and comorbid diagnoses.(51) HPA axis function can be assessed through measurement of CRH, ACTH and cortisol in a variety of samples, including blood plasma and cerebrospinal fluid (CSF),(52,53) or less invasive approaches such as saliva and hair cortisol levels.”
BackgroundDepressive disorders in the elderly and dementia: An update
Dias, N. S., Barbosa, I. G., Kuang, W., & Teixeira, A. L. (2020) · Dementia & Neuropsychologia · doi:10.1590/1980-57642020dn14-010001 · Cited by 41
Mikkelsen, S., Forman, J. L., Fink, S., Vammen, M. A., Thomsen, J. F., Grynderup, M. B., Hansen, Å. M., Kærlev, L., Kolstad, H. A., Rugulies, R., et al. (2017) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-017-1241-z · Cited by 41
“…et al. 2008; Kumari et al. 2011; Matthews et al. 2006), cancer (Abercrombie et al. 2004; Sephton et al. 2000), depression (Kudielka and Wust 2010; Stetler and Miller 2011), and upper respiratory illness (Edwards et al. 2003; Smyth et al. 1997), all of which have also been associated with…”
BackgroundAdrenal gland volume, intra-abdominal and pericardial adipose tissue in major depressive disorder
Kahl, K. G., Schweiger, U., Pars, K., Kunikowska, A., Deuschle, M., Gutberlet, M., Lichtinghagen, R., Bleich, S., Hüper, K., & Hartung, D. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.04.008 · Cited by 40
Gut microbiota in mental health and depression: role of pre/pro/synbiotics in their modulation
Methiwala, H. N., Vaidya, B., Addanki, V. K., Bishnoi, M., Sharma, S. S., & Kondepudi, K. K. (2021) · Food & Function · doi:10.1039/d0fo02855j · Cited by 41
Deidda, G., & Biazzo, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753915 · Cited by 40
Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers
Vogel, S. W. N., Bijlenga, D., Verduijn, J., Bron, T. I., Beekman, A. T. F., Kooij, J. J. S., & Penninx, B. W. J. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.02.009 · Cited by 40
Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding
Steinberg, L. J., Rubin‐Falcone, H., Galfalvy, H., Kaufman, J., Miller, J. M., Sublette, M. E., Cooper, T. B., Min, E., Keilp, J. G., Stanley, B., et al. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz009 · Cited by 40
“, 2006a), and with hyperactive HPA axis responses to stress, which are state dependent (Cowen, 2010; Stetler and Miller, 2011).”
BackgroundEid, R. S., Lieblich, S. E., Duarte‐Guterman, P., Chaiton, J. A., Mah, A., Wong, S. J., Wen, Y., & Galea, L. A. M. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.104651 · Cited by 40
Bleibel, L., Sokołowska, P., Henrykowska, G. A., Owczarek, J., & Wiktorowska‐Owczarek, A. (2025) · Pharmaceuticals · doi:10.3390/ph18060867 · Cited by 40
Mifepristone as a Therapeutic Agent in Psychiatry
Howland, R. H. (2013) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20130513-01 · Cited by 36
Current Understanding of the Neurobiology and Longitudinal Course of Geriatric Depression
Weisenbach, S. L., & Kumar, A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0463-y · Cited by 40
Determinants of cortisol awakening responses to naps and nighttime sleep
Devine, J. K., & Wolf, J. M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.016 · Cited by 40
Metadata
- Authors
- Stetler, C., & Miller, G. E.
- Affiliations
- Furman University (US)
- University of British Columbia (CA)
- Corresponding author
- Stetler, Cinnamon
- ORCID
- Miller, Gregory E.
- Venue
- Psychosomatic Medicine
- Published
- 2011-02
- Volume
- 73
- Issue
- 2
- Pages
- 114-126
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2325341530
- Semantic Scholar
- 8dd36c89fdc21f4d365839c99e1ae8e38ebdcccb
- Cited by
- 1,123
- References
- 32
- Citations by year
- 2026: 54 · 2025: 62 · 2024: 56 · 2023: 84 · 2022: 96 · 2021: 100 · 2020: 90 · 2019: 85 · 2018: 81 · 2017: 69 · 2016: 95 · 2015: 70 · 2014: 61 · 2013: 59 · 2012: 40
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, corticotropin-releasing factor, atypical depression, endogenous depression, psychotic depression, hospitalized older adults, methodological quality, gender differences
- MeSH terms
- Adolescent, Adrenocorticotropic Hormone, Adult, Child, Corticotropin-Releasing Hormone, Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Research, Bibliometrics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.